I-612 30 day FRN

16026

Federal Register / Vol. 84, No. 74 / Wednesday, April 17, 2019 / Notices

5601 Fishers Lane, MSC–9823 Rockville, MD
20852, 240–292–0189, reed.shabman@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Clinical Trial
Planning and Implementation Grant (R34 and
U01).
Date: June 7, 2019.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Reed Solomon Shabman,
Ph.D., Scientific Review Officer Scientific
Review Program DEA/NIAID/NIH/DHHS,
5601 Fishers Lane, MSC–9823 Rockville, MD
20852, 240–292–0189, reed.shabman@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 11, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07643 Filed 4–16–19; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings

amozie on DSK9F9SC42PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Research
Enhancement Award R15.
Date: May 24, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Inna Gorshkova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of

VerDate Sep<11>2014

18:23 Apr 16, 2019

Jkt 247001

Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1784, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Exploration
of Antimicrobial Therapeutics and
Resistance.
Date: June 3–4, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Harborplace Hotel, 202
East Pratt Street, Baltimore, MD 21202.
Contact Person: Susan Daum, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
Bethesda, MD 20892, 301–827–7233,
[email protected].
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Biology Development and Disease
Study Section.
Date: June 4–5, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Georgetown, 2201
M Street NW, Washington, DC 20036.
Contact Person: Aruna K. Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, [email protected].
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Interventions to Prevent and Treat
Addictions Study Section.
Date: June 6–7, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Miriam Mintzer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 3108,
Bethesda, MD 20892, (301) 523–0646,
[email protected].
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Risk and Disease Prevention
Study Section.
Date: June 10–11, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Stacey FitzSimmons,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, (301) 451–
9956, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)

PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

Dated: April 11, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–07644 Filed 4–16–19; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0030]

Agency Information Collection
Activities; Extension, Without Change,
of a Currently Approved Collection:
Application for Waiver of the Foreign
Residence Requirement of the
Immigration and Nationality Act
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: 30-Day notice.
AGENCY:

The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The purpose of this notice is to
allow an additional 30 days for public
comments.
DATES: The purpose of this notice is to
allow an additional 30 days for public
comments. Comments are encouraged
and will be accepted until May 17,
2019.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, must be
directed to the OMB USCIS Desk Officer
via email at dhsdeskofficer@
omb.eop.gov. All submissions received
must include the agency name and the
OMB Control Number 1615–0030 in the
subject line.
You may wish to consider limiting the
amount of personal information that you
provide in any voluntary submission
you make. For additional information
please read the Privacy Act notice that
is available via the link in the footer of
http://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
USCIS, Office of Policy and Strategy,
Regulatory Coordination Division,
Samantha Deshommes, Chief, 20
Massachusetts Avenue NW,
Washington, DC 20529–2140,
Telephone number (202) 272–8377
SUMMARY:

E:\FR\FM\17APN1.SGM

17APN1

Federal Register / Vol. 84, No. 74 / Wednesday, April 17, 2019 / Notices
(This is not a toll-free number;
comments are not accepted via
telephone message.). Please note contact
information provided here is solely for
questions regarding this notice. It is not
for individual case status inquiries.
Applicants seeking information about
the status of their individual cases can
check Case Status Online, available at
the USCIS website at http://
www.uscis.gov, or call the USCIS
National Customer Service Center at
(800) 375–5283; TTY (800) 767–1833.
SUPPLEMENTARY INFORMATION:
Comments
The information collection notice was
previously published in the Federal
Register on November 23, 2018, at 83
FR 60885, allowing for a 60-day public
comment period. USCIS did receive 5
comments in connection with the 60day notice.
You may access the information
collection instrument with instructions,
or additional information by visiting the
Federal eRulemaking Portal site at:
http://www.regulations.gov and enter
USCIS–2008–0012 in the search box.
Written comments and suggestions from
the public and affected agencies should
address one or more of the following
four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.

amozie on DSK9F9SC42PROD with NOTICES

Overview of This Information
Collection

18:23 Apr 16, 2019

Jkt 247001

Dated: April 11, 2019.
Jerry L. Rigdon,
Deputy Chief, Regulatory Coordination
Division, Office of Policy and Strategy, U.S.
Citizenship and Immigration Services,
Department of Homeland Security.
[FR Doc. 2019–07603 Filed 4–16–19; 8:45 am]
BILLING CODE 9111–97–P

DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–6143–N–01]

(1) Type of Information Collection
Request: Extension, Without Change, of
a Currently Approved Collection.
(2) Title of the Form/Collection:
Application for Waiver of the Foreign
Residence Requirement of Section
212(e) of the Immigration and
Nationality Act.

VerDate Sep<11>2014

(3) Agency form number, if any, and
the applicable component of the DHS
sponsoring the collection: I–612; USCIS.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals or
households. This information collection
is necessary and may be submitted only
by an alien who believes that
compliance with foreign residence
requirements would impose exceptional
hardship on his or her spouse or child
who is a citizen of the United States, or
a lawful permanent resident; or that
returning to the country of his or her
nationality or last permanent residence
would subject him or her to persecution
on account of race, religion, or political
opinion. Certain aliens admitted to the
United States as exchange visitors are
subject to the foreign residence
requirements of section 212(e) of the
Immigration and Nationality Act (the
Act). Section 212(e) of the Act also
provides for a waiver of the foreign
residence requirements in certain
instances.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The estimated total number of
respondents for the information
collection I–612 is 7,200 and the
estimated hour burden per response is
.333 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total estimated annual
hour burden associated with this
collection is 2,398 hours.
(7) An estimate of the total public
burden (in cost) associated with the
collection: The estimated total annual
cost burden associated with this
collection of information is $882,000.

SUPPORT for Patients and
Communities Act; Establishment of
Funding Formula
Office of the Assistant
Secretary for Policy Development and
Research, HUD.
ACTION: Notice.
AGENCY:

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

16027

This document establishes the
funding formula that would allocate
funds ‘‘for assistance to States to
provide individuals in recovery from a
substance use disorder stable, temporary
housing for a period of not more than
2 years or until the individual secures
permanent housing, whichever is
earlier’’, as enacted by the SUPPORT for
Patients and Communities Act on
October 24, 2018. The law requires that
the formula be established by the
Secretary ‘‘not later than 60 days after
the date of enactment’’. At this time, no
funds have been appropriated for this
program.
FOR FURTHER INFORMATION CONTACT: For
questions on how this formula was
developed, contact Todd M. Richardson,
General Deputy Assistant Secretary,
Office of Policy Development and
Research, Department of Housing and
Urban Development, 451 Seventh Street
SW, Room 8100, Washington, DC
20410–6000; telephone number 202–
402–5706, or send an email to
[email protected]. (These
are not toll-free telephone numbers.) A
text telephone is available for persons
with hearing or speech impairments at
800–877–8339. Additional copies of this
notice are available through HUD User
at 800–245–2691 for a small fee to cover
duplication and mailing costs.
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. This Notice
Section 8071 of the ’’Substance Use–
Disorder Prevention that Promotes
Opioid Recovery and Treatment for
Patients and Communities Act’’ or the
’’SUPPORT for Patients and
Communities Act’’ (Pub. L. 115–271,
approved October 24, 2018) (the Act),
the Secretary of HUD must establish a
funding formula within 60 days of
enactment to allocate whatever funds
are appropriated ‘‘for assistance to
States to provide individuals in
recovery from a substance use disorder
stable, temporary housing for a period of
not more than 2 years or until the
individual secures permanent housing,
whichever is earlier’’. The purpose of
this notice is to establish this formula.
II. Data Used To Establish the Formula
The Act has specific criteria that the
Secretary must use to establish the
formula. Those criteria first limit the
number of eligible states 1 to receive
funding to just those ‘‘States with an
age-adjusted rate of drug overdose
deaths that is above the national
1 Section 8071 (g) ‘‘includes any State as defined
in section 102 of the Housing and Community
Development Act of 1974 (42 U.S.C. 5302) and the
District of Columbia’’.

E:\FR\FM\17APN1.SGM

17APN1